Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 3,803 | 3,177 | 11,964 | 1,190 | 0 |
| Gross Profit | 3,803 | 3,177 | 11,964 | 1,190 | N/A |
| Operating Expenses | 28,991 | 21,249 | 12,201 | 7,426 | 9,566 |
| Operating Income | -25,188 | -18,072 | -237 | -6,236 | -9,566 |
| Interest Expense | 0 | 0 | 0 | 66 | 95 |
| Other Income | 101 | 126 | -3,756 | 0 | -180 |
| Pre-tax Income | -25,087 | -17,946 | -3,993 | -6,302 | -9,841 |
| Income Tax | -397 | -201 | -30 | -31 | -35 |
| Net Income Continuous | -24,690 | -17,745 | -3,963 | -6,271 | -9,806 |
| Net Income | $-24,690 | $-17,745 | $-3,963 | $-6,271 | $-9,806 |
| EPS Basic Total Ops | -36.02 | -30.62 | -26.65 | -68.43 | -109.13 |
| EPS Basic Continuous Ops | -36.12 | -30.48 | -34.54 | -68.45 | -109.14 |
| EPS Diluted Total Ops | -36.02 | -30.62 | -26.65 | -68.43 | -109.13 |
| EPS Diluted Continuous Ops | -36.12 | -30.48 | -34.54 | -68.45 | -109.14 |
| EBITDA(a) | $-24,367 | $-17,289 | $669 | $-5,211 | $-8,380 |